Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07476157
PHASE1
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects
Official title: An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and the Pharmacokinetics of AD-118 Compared to AD-1181 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2026-04
Completion Date
2026-05
Last Updated
2026-03-17
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AD-118, AD-1181
Single-dose oral administration of AD-118 or AD-1181, according to randomized sequence.
Locations (1)
H PLUS YANGJI HOSPITAL, Seoul
Seoul, South Korea